What was recalled
The U.S. Food and Drug Administration (FDA) has issued a Class II recall for a specific medical device manufactured by Baxter Healthcare Corporation. This action targets the Baxter Novum IQ Syringe Pump, specifically identifying Model Number 40800BAXUS as the affected product. It is important to understand that this recall is not broad or vague; it applies strictly to this exact model and its associated unique device identifiers. The scope of the recall encompasses all serial numbers for the U5413765852428 Universal Device Identifier (UDI-DI). If you are looking at a pump with this specific model number and UDI, it falls within the boundaries of this official notice.
This equipment was distributed nationwide across the United States, meaning it is not limited to a single region or a handful of states. The distribution pattern confirms that these pumps were sold and utilized in a wide array of locations, including Alaska, Alabama, Arkansas, Arizona, California, Colorado, Florida, Georgia, Hawaii, Iowa, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Michigan, Minnesota, Mississippi, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, and West Virginia. The sheer geographic spread indicates that these devices were integrated into healthcare systems across the country, from large metropolitan hospitals to smaller clinics in more rural areas.
The recall was officially announced on August 11, 2026. Because this is a Class II recall, it signifies a situation where the defective product might cause temporary health problems or pose a slight threat of serious injury, but is not expected to cause serious adverse health consequences or death. However, the specific nature of the defect—a software issue during Volume/Time multi-syringe infusions—requires careful attention. Healthcare providers and patients using this device should verify their equipment against the model number 40800BAXUS immediately. The recall does not currently state a remedy, repair, or replacement plan in the initial report, which underscores the importance of identifying whether you possess this specific unit right now.
Understanding the distribution pattern helps clarify why this recall is significant. With presence in states as diverse as New York, Texas, and California, the potential impact is substantial. The device is a critical tool for administering precise amounts of medication over time, often used in intensive care or post-operative settings. Knowing exactly what was recalled—the Baxter Novum IQ Syringe Pump, Model 40800BAXUS, UDI-DI 05413765852428, all serial numbers—allows medical staff to isolate the risk and take appropriate steps to ensure patient safety without unnecessary panic over other compatible or unrelated devices.
The hazard, explained
To understand why this recall matters, it helps to first look at how the Baxter Novum IQ Syringe Pump is designed to work in a typical clinical setting. These devices are precision instruments used to deliver fluids, medications, or nutrients directly into a patient’s bloodstream over a specific period. A common method for doing this is called Volume/Time (VOT) infusion. In this mode, the nurse or clinician programs the pump with two key pieces of information: the total volume of fluid that needs to be delivered and the exact amount of time it should take to deliver that entire amount. The pump then calculates the precise speed required to hit that target.
The specific issue identified in this Class II recall occurs during a critical moment in that process: when a syringe runs out and needs to be swapped out for a new one, but only if there is still a remaining Volume To Be Infused (VTBI). Imagine a scenario where a patient requires 500 milliliters of medication over ten hours. After five hours, the first syringe is empty. The clinician replaces it with a fresh one to deliver the remaining volume. Under normal circumstances, the pump would recognize this swap and continue infusing at the correct rate.
However, the software flaw in Model Number 40800BAXUS can disrupt this continuity. When the original syringe reaches empty and is replaced while a VTBI remains, the device may fail to properly manage the transition. Instead of seamlessly continuing the infusion at the programmed rate for the remaining volume, the software issue can cause the pump to stop delivering the medication entirely or deliver it at an incorrect rate. This is not a minor glitch; it is a fundamental breakdown in the device’s ability to execute the physician’s order.
The physical harm that can result from this mechanism is significant and potentially life-threatening. If the pump stops infusing, the patient may miss critical doses of essential medications, such as antibiotics, pain relievers, or sedatives. In intensive care settings, where fluid balance and medication timing are tightly controlled, even a short interruption can lead to clinical deterioration, hemodynamic instability, or other adverse health events. Conversely, if the pump delivers too much or too little fluid due to miscalculation during the swap, it could cause overdose complications or under-treatment of the condition being managed. This is why the FDA has classified this as a Class II recall, indicating that while not immediately dangerous in all cases, the failure poses a serious threat to patient safety if left unaddressed.
Who is most at risk
The individuals most directly affected by this recall are patients who rely on the Baxter Novum IQ Syringe Pump (Model Number 40800BAXUS) for critical medical treatments, particularly those requiring precise, continuous delivery of medication over a set period. Because this device is classified as a Class II medical device by the FDA, it is typically used in hospital settings, outpatient clinics, or specialized home care environments where volume-to-time (VOT) infusions are medically necessary. This means the risk is concentrated among patients who depend on these pumps to manage conditions such as pain management, antibiotic therapy, chemotherapy, or pediatric fluid and nutrient administration. If you or a loved one is currently undergoing treatment that involves syringe-based infusion pumps, there is a possibility that this specific equipment is part of your care plan.
The specific nature of the hazard—software errors occurring when replacing an empty syringe while a Volume To Be Infused (VTBI) remains active—creates a unique vulnerability for patients who require uninterrupted therapy. When a syringe runs out and must be swapped by a nurse or caregiver, the pump should seamlessly continue infusing the remaining prescribed volume. However, if the software fails during this transition, the flow of medication could stop unexpectedly, slow down significantly, or potentially deliver an incorrect dose. For patients with acute conditions, such as those requiring tight control of blood pressure, heart rhythm, or insulin levels, even a brief interruption or dosage error can have serious immediate health consequences. The risk is not just about the device breaking; it is about the reliability of the life-sustaining or symptom-managing therapy being compromised at a critical moment.
Vulnerable populations are particularly at risk in this scenario. Elderly patients, who often have diminished physiological reserves and may be on multiple medications, might not tolerate sudden changes in drug delivery as well as younger, healthier individuals. Similarly, pediatric patients, including infants and children, are highly sensitive to dosage variations because their body weight is low relative to adult dosing standards. A small error in infusion rate can represent a disproportionately large amount of medication per kilogram of body weight, potentially leading to toxicity or therapeutic failure. Additionally, patients with chronic illnesses who rely on these pumps for long-term management at home may face heightened anxiety and physical risk if the device fails without immediate professional assistance, especially if they are managing their own care or have limited support systems.
It is also important to consider the healthcare providers themselves. Nurses, physicians, and home health aides who operate these devices are at risk of making clinical errors under pressure. If the pump behaves unpredictably during a syringe change, it can cause confusion and delay in treatment, indirectly putting the patient at risk. Therefore, the "who is at risk" group extends beyond the patient to include the medical staff responsible for monitoring the device’s performance. If you are a caregiver or healthcare professional using this model, your ability to provide safe, effective care is directly impacted by the software stability of the pump. Recognizing who is involved helps clarify why prompt attention to this recall is essential for maintaining safety across the entire care ecosystem.
How to tell if you have the recalled item
When a medical device recall is announced, the most immediate and practical step you can take is to verify whether your specific equipment falls under the affected batch. In this case, Baxter Healthcare Corporation has issued a Class II recall for a very specific piece of infusion technology. Because medical devices often look similar at a glance, relying solely on the brand name is not enough. You must locate and cross-reference the precise model number and the unique device identifier to be certain you are dealing with the product described in the FDA notice.
The primary target of this recall is the Baxter Novum IQ Syringe Pump. To confirm if you have this device, look at the exterior casing for the "Baxter" brand logo and the "Novum IQ" model designation. However, the most critical piece of information is the Model Number. You must find the label on the pump that clearly states Model Number 40800BAXUS. If your device lists any other model number, it is not part of this specific recall action. This alphanumeric code is the key identifier that links your hardware to the software issue regarding Volume/Time multi-syringe infusions.
In addition to the model number, you need to check the Universal Device Identifier (UDI). Look for a barcode or printed string on the device label that begins with 05413765852428. This UDI-DI is unique to this specific configuration of the Novum IQ pump. While the recall notice indicates that all serial numbers for this model and UDI are included, verifying the UDI ensures you are looking at the correct product line before proceeding with further checks.
If you are a patient or caregiver using this device at home, check the documentation packet that originally came with the pump. The sales receipt, warranty card, or user manual should also list the model number and serial number. If you have lost these papers, the physical label on the unit itself is your definitive source. For healthcare facilities in the states listed in the nationwide distribution pattern—including Illinois, California, Florida, Texas, New York, and others—inventory logs or asset management tags attached to the pump will contain this data.
It is important to note that the recall does not specify a particular color or size of the syringe pump, as the issue is rooted in software behavior during specific infusion scenarios rather than physical hardware defects. Therefore, visual inspection alone cannot rule out the recall; you must rely on the printed model number and UDI. If your device matches Model 40800BAXUS with UDI-DI 05413765852428, you have the recalled item. If it does not match these exact identifiers, this specific software hazard does not apply to your device.
What to do — step by step
If you are a patient, caregiver, or healthcare professional currently using the Baxter Novum IQ Syringe Pump, Model Number 40800BAXUS, your immediate priority is to ensure that the device is not being relied upon for critical medical tasks until its status is clarified. The U.S. Food and Drug Administration (FDA) has issued this Class II recall due to a specific software vulnerability that can disrupt infusion delivery. Because the official remedy for this recall has not been explicitly stated in the current public documentation, you cannot assume that a standard repair kit, replacement part, or automatic return shipping label is available at this time. This uncertainty requires a proactive and careful approach to managing your situation safely. First, if you are using this pump for any ongoing treatment, you must immediately stop using the Baxter Novum IQ Syringe Pump, Model Number 40800BAXUS. The hazard involves a software error that may occur during Volume/Time (VOT) multi-syringe infusion when a syringe is replaced while a Volume To Be Infused (VTBI) remains. In practical terms, this means the pump might fail to deliver the correct amount of medication after you swap out an empty syringe for a new one. This is not a minor inconvenience; it is a potential gap in care that could lead to under-dosing or over-dosing depending on how the software misinterprets the transition between syringes. Do not attempt to bypass this issue by continuing use "just in case" or by trying to troubleshoot the software yourself. Medical devices with known software flaws should be treated as non-functional until a professional resolves the issue. Second, you need to verify exactly which unit you have. Locate the serial number on the pump and confirm it matches the affected batch (all serial numbers for UDI-DI 05413765852428 are included). Keep this information handy, as you will need it for any communication with Baxter Healthcare Corporation or your local healthcare provider. Do not throw the device away yet, as it may be required for inspection or return if a remedy is later established. Third, contact Baxter Healthcare Corporation directly to inquire about the current status of the remedy. Since the recall announcement does not specify whether you will receive a repair, a refund, or a replacement, your only path to resolution is through their official customer support channels. Ask them specifically what steps they are taking to rectify the software issue and how they plan to return the device to safe working order. If you are a healthcare facility, ensure that your clinical engineering or biomedical equipment department is also aware of this recall so they can inventory all affected units and coordinate with Baxter on a bulk resolution strategy. Finally, if you cannot reach Baxter immediately, consult your primary care provider or hospital pharmacy. They can help you arrange alternative infusion methods for any necessary treatments in the interim. Your health and safety depend on accurate medication delivery, so do not delay in seeking professional guidance until the pump is cleared for use or replaced.Your refund, repair, or replacement options
When you encounter an official product recall, the most immediate and practical question is often, "What do I get in return?" It is completely normal to feel a mix of relief that the issue has been identified and anxiety about how to resolve it. In this specific case involving the Baxter Novum IQ Syringe Pump, Model Number 40800BAXUS, we must look closely at what the regulatory record actually provides regarding your financial or functional restitution. It is important to approach this with clarity and patience, as the remedy for medical device recalls can vary significantly depending on the nature of the defect and the agency involved.
According to the official facts provided by the U.S. Food and Drug Administration (FDA) for this Class II recall, the specific remedy—whether that be a full refund, a complimentary repair of the software issue, or a direct replacement with a corrected unit—is currently not stated in the available documentation. This does not mean that no action will be taken on your behalf; rather, it indicates that the standard "one-size-fits-all" resolution terms have not been publicly detailed in this initial recall notice. In many medical device recalls, especially those involving software glitches like the Volume/Time (VOT) multi-syringe infusion issue described here, the manufacturer often provides a software patch or update rather than a physical replacement. However, without explicit confirmation in these records, we cannot assume that hardware will be swapped out or that monetary refunds will be issued.
Because the remedy details are absent from this specific data set, your next steps must focus on direct communication with the responsible party. Baxter Healthcare Corporation is the entity managing this recall. You should not rely on general consumer protection websites for the final word on your compensation or repair options. Instead, you need to contact Baxter directly through their official recall channels. While the specific phone numbers and email addresses are not listed in the provided facts, they are typically found on the FDA’s public recall database page for this specific entry or on Baxter’s own medical professional support website. When you reach out, have your device’s serial number and the Unique Device Identifier (UDI-DI) 05413765852428 ready, as these will help them locate your specific unit in their system quickly.
It is also crucial to understand that in the medical field, "remedy" often prioritizes patient safety over financial restitution. The primary goal of this recall is to ensure the software no longer fails when a syringe is replaced while a Volume To Be Infused (VTBI) remains. Therefore, your "option" may primarily be receiving instructions on how to update or reset the device safely. Do not attempt to fix the software yourself unless explicitly instructed by Baxter’s technical support team, as improper handling could void warranties or compromise the device's integrity. Wait for their official communication, which should outline whether you will receive a repair kit, a software update guide, or a replacement pump. Until that information is released, your best course of action is to document your ownership and stay in close contact with Baxter’s recall coordinators to ensure you are included in the first wave of solutions once they are defined.
What can happen if you ignore it
When a medical device like the Baxter Novum IQ Syringe Pump fails to deliver medication as programmed, the stakes are rarely just about inconvenience. They are about physiology. The specific hazard identified in this recall involves a software glitch that occurs during Volume/Time (VOT) multi-syringe infusions. In this scenario, the pump is managing two or more syringes sequentially. If one syringe empties and is replaced while a Volume To Be Infused (VTBI) remains for the overall process, the software may not correctly calculate the new delivery rate or total volume. Ignoring this defect means continuing to rely on a machine that has lost its ability to accurately measure time and fluid volume in a critical phase of treatment.
The immediate consequence of this software error is unpredictable dosing. You might receive significantly less medication than prescribed, leaving a condition untreated when it requires constant therapeutic levels. Conversely, the pump might deliver a bolus or rapid infusion that was never intended, potentially causing an overdose. In clinical settings, such as intensive care or post-operative recovery, medications are often titrated to the milligram per hour. A deviation of even a small percentage can lead to hemodynamic instability, respiratory depression, or inadequate pain control. For patients with narrow therapeutic indices—where the difference between a helpful dose and a harmful one is tiny—the margin for error does not exist.
Beyond the direct pharmacological risks, ignoring the recall introduces a dangerous false sense of security. The Novum IQ is designed to be a reliable partner in care, providing alarms and visual cues when things go wrong. However, because this is a software logic failure rather than a simple mechanical jam or empty sensor trigger, the device may not alert you that it has stopped infusing correctly. You might look at the screen, see numbers that appear normal, and assume the medication is flowing. In reality, the flow could have stalled entirely or drifted off-target. This disconnect between what the monitor says and what the patient receives is particularly insidious because it delays intervention until a physiological crisis becomes apparent.
Furthermore, this issue disrupts the continuity of care. If the pump fails to switch syringes correctly or miscalculates the remaining volume, the clinical team must interrupt therapy to troubleshoot a complex electronic error rather than focusing on patient assessment. This delay can be critical in time-sensitive treatments. While the recall notice does not currently list specific injury reports, the potential for harm is inherent in the nature of the malfunction. Continuing to use a device with known software defects that affect volume accuracy is akin to driving a car with a broken speedometer; you may feel like you are moving at a safe pace, but you have no way of knowing if you are going too fast or not far enough. For patients dependent on these pumps for life-sustaining therapies, ignoring the recall puts them at unnecessary risk of adverse drug events, prolonged hospital stays, and preventable complications.
Staying safe: broader tips
Medical devices like syringe pumps are sophisticated tools that bridge the gap between complex technology and patient care. While specific software glitches can happen, as seen in recent regulatory updates, your long-term safety relies on a mindset of proactive maintenance and routine verification. The most effective way to prevent adverse events is to treat these devices not as "set it and forget it" appliances, but as critical pieces of medical equipment that require regular human oversight.
First, establish a strict routine for visual and functional checks before every use. For any infusion pump, this means inspecting the syringe barrel for cracks or defects, ensuring the plunger is seated correctly, and verifying that all connections are tight and leak-free. Do not rely solely on the device’s internal sensors to catch every error. If you notice unusual noises, inconsistent flow rates, or if the screen displays unexpected warnings, pause immediately. Trust your instincts as a caregiver; if something feels "off," it likely is. Report these observations to your healthcare provider or the manufacturer, even if they seem minor at first.
Secondly, stay informed about safety communications relevant to your specific type of equipment. Subscribe to alerts from the FDA’s MedWatch program and your device manufacturer directly. These agencies do not just announce recalls; they often publish detailed Field Safety Notices that explain nuanced issues which may not yet warrant a full recall but are important for awareness. Understanding the broader landscape of medical device safety helps you recognize patterns and stay vigilant against emerging risks.
Finally, never hesitate to ask questions or seek second opinions regarding your treatment plan. If you are using a device at home, ensure you have received comprehensive training from a qualified professional. Ask about alternative devices if you have concerns about reliability, and keep a log of any maintenance performed on the equipment. By combining technical vigilance with open communication with your healthcare team, you create a robust safety net that protects you beyond the scope of any single product recall.